Vaccines Capability Area

April 19, 2024 0

Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Vaccines Capability Area is to conduct research in order to develop lead candidate vaccines and pretreatments that can be administered Read More

Microphysiological Systems To Expand Diagnostic Capabilities

April 19, 2024 0

Anticipated Release Date: Q2FY24 Develop a microphysiological system that realistically mimics human physiological responses to threat exposures for rapid discovery of diagnostic biomarkers. Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium Read More

Consolidated Nerve Agent Treatment System

April 19, 2024 0

Anticipated Release Date: Q1FY25 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations Read More

Small Molecule Therapeutics

April 19, 2024 0

Anticipated Release Date: Q1FY24 OR Q2FY24 Small Molecule Therapeutics Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end Read More

Therapeutics Capability Area

April 19, 2024 0

Anticipated Release Date: Q3FY24 OR Q4FY24 Multiple Topics TBD—Possible 3 or 4 The goal of the Therapeutics Capability Area is to develop lead candidate medical treatments and pharmaceuticals that, when administered after exposure to a biological Read More

ChemDx Expansion

April 19, 2024 0

Anticipated Release Date: Q3FY24 Develop a diagnostic prototype strip, compatible with the ChemDx device, able to diagnose opioid exposure. Additional test strips able to differentiate between bacterial vs. viral infection, pre-symptomatic, contagiousness, or disease severity may Read More

VaporAgent Demasking –Easily Readable

April 19, 2024 0

VaporAgent Demasking –Easily Readable Develop low-burden, low-cost detection capabilities for chemical threat vapors to facilitate doffing PPE as part of the M256A2 modernization effort. Responding to this opportunity requires membership in the Countering Weapons of Read More

Shipboard Isolation System (SIS) / PPMT

April 19, 2024 0

Anticipated Release Date: Q4FY24 The SIS program provides the capability to temporarily isolate or quarantine personnel to prevent the spread of infection and safely evacuate patients for transfer off the ship. Capability will be used on Read More

1 2